The endocannabinoid system and its therapeutic implications in rheumatoid arthritis

International Immunopharmacology

Volumn 26, Issue 1, 2015, Pages 86-91

  Gui, Huan ^a,b   Tong, Qiang ^b   Qu, Wenchun ^c   Mao, Chen Mei ^a   Dai, Sheng Ming ^b  

^a CHILDREN S HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c MAYO CLINIC   (United States)

Author keywords

Cannabinoid receptors; Drug therapy; Endocannabinoid system; Endocannabinoids; Rheumatoid arthritis

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABIS; CHEMOKINE; COLLAGENASE 3; ENDOCANNABINOID; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; STROMELYSIN; TETRAHYDROCANNABINOL; TUMOR NECROSIS FACTOR ALPHA; VANILLOID RECEPTOR 1; CANNABINOID; CANNABINOID RECEPTOR; CYTOKINE;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BONE EROSION; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; EXTRACELLULAR MATRIX; FEEDBACK SYSTEM; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; MACROPHAGE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; SYNOVIAL FLUID; SYNOVIOCYTE; T LYMPHOCYTE; ANIMAL; ARTHRITIS, RHEUMATOID; DRUG EFFECTS; FIBROBLAST; IMMUNOLOGY; OSTEOBLAST; PATHOLOGY;

ANIMALS; ARTHRITIS, RHEUMATOID; CANNABINOIDS; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOKINES; ENDOCANNABINOIDS; FIBROBLASTS; HUMANS; OSTEOBLASTS; RECEPTORS, CANNABINOID;

EID: 84925428378     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.03.006     Document Type: Review

References (87)

1. L.A. Matsuda, S.J. Lolait, and M.J. Brownstein Structure of a cannabinid receptor and functional expression of the cloned cDNA Nature 346 1990 561 564
2. M. Herkenham, A.B. Lynn, M.D. Little, M.R. Johnson, L.S. Melvin, and B.R. de Costa et al. Cannabinoid receptor localization in brain Proc. Natl. Acad. Sci. U. S. A. 87 1990 1932 1936
3. M. Herkenham Cannabinoid receptor localization in brain: relationship to motor and reward systems Ann. N. Y. Acad. Sci. 654 1992 19 32
4. S. Munro, K.L. Thomas, and M. Abu-shaar Molecular characterization of a peripheral receptor for cannabinoids Nature 365 1993 61 65
5. A.C. Howlett, F. Barth, T.I. Bonner, G. Cabral, P. Casellas, and W.A. Devane et al. Classification of cannabinoid receptors Pharmacol. Rev. 54 2002 161 202
6. J.T. Castaneda, A. Harui, S.M. Kiertscher, J.D. Roth, and M.D. Roth Differential expression of intracellular and extracellular CB(2) cannabinoid receptor protein by human peripheral blood leukocytes J. Neuroimmune Pharmacol. 8 2013 323 332
7. H. Gui, X. Liu, Z.W. Wang, D.Y. He, D.F. Su, and S.M. Dai Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis Rheumatology (Oxford) 53 2014 802 809
8. K. Ray Rheumatoid arthritis: clue to role of cannabinoid receptors in RA Nat. Rev. Rheumatol. 10 2014 128
9. O. Ofek, M. Karsak, N. Leclerc, M. Fogel, B. Frenkel, and K. Wright et al. Peripheral cannabinoid receptor, CB2, regulates bone mass Proc. Natl. Acad. Sci. U. S. A. 103 2006 696 701
10. O. Ofek, M. Attar-Namdar, V. Kram, M. Dvir-Ginzberg, R. Mechoulam, and A. Zimmer et al. CB2 cannabinoid receptor targets mitogenic Gi protein-cyclin D1 axis in osteoblasts J. Bone Miner. Res. 26 2011 308 316
11. M. Rajesh, P. Mukhopadhyay, G. Hasko, J. Huffman, K. Mackie, and P. Pacher CB2 cannabinoid receptor agonists attenuate TNF-a-induced human vascular smooth muscle cell proliferation and migration Br. J. Pharmacol. 153 2008 347 357
12. M. Wang, J.M. Abais, N. Meng, Y. Zhang, J.K. Ritter, and P.L. Li et al. Upregulation of cannabinoid receptor-1 and fibrotic activation of mouse hepatic stellate cells during Schistosoma J. infection: role of NADPH oxidase Free Radic. Biol. Med. 71 2014 109 120
13. T. Jourdan, G. Godlewski, R. Cinar, A. Bertola, G. Szanda, and J. Liu et al. Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes Nat. Med. 19 2013 1132 1140
14. E. Ryberg, N. Larsson, S. Sjögren, S. Hjorth, N.-O. Hermansson, and J. Leonova et al. The orphan receptor GPR55 is a novel cannabinoid receptor Br. J. Pharmacol. 152 2007 1092 1101
15. V. Gasperi, E. Dainese, S. Oddi, A. Sabatucci, and M. Maccarrone GPR55 and its interaction with membrane lipids: comparison with other endocannabinoid-binding receptors Curr. Med. Chem. 20 2013 64 78
16. S. O'Sullivan Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors Br. J. Pharmacol. 152 2007 576 582
17. B. Costa, G. Giagnoni, C. Franke, A.E. Trovato, and M. Colleoni Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation Br. J. Pharmacol. 143 2004 247 250
18. M. Maccarrone, T. Lorenzon, M. Bari, G. Melino, and A. Finazzi-Agro Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors J. Biol. Chem. 275 2000 31938 31945
19. W.A. Devane, L. Hanus, A. Breuer, R.G. Pertwee, L.A. Stevenson, and G. Griffin et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 1992 1946 1949
20. R. Mechoulam, S. Ben-Shabat, L. Hanus, M. Ligumsky, N.E. Kaminski, and A.R. Schatz et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Biochem. Pharmacol. 50 1995 83 90
21. L. Hanus, S. Abu-Lafi, E. Fride, A. Breuer, Z. Vogel, and D.E. Shalev et al. 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor Proc. Natl. Acad. Sci. U. S. A. 98 2001 3662 3665
22. A.C. Porter, J.M. Sauer, M.D. Knierman, G.W. Becker, M.J. Berna, and J. Bao et al. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor J. Pharmacol. Exp. Ther. 301 2002 1020 1024
23. S.M. Huang, T. Bisogno, M. Trevisani, A. Al-Hayani, L. De Petrocellis, and F. Fezza et al. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors Proc. Natl. Acad. Sci. U. S. A. 99 2002 8400 8405
24. I. Brown, M.G. Cascio, K.W. Wahle, R. Smoum, R. Mechoulam, and R.A. Ross et al. Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines Carcinogenesis 31 2010 1584 1591
25. N. Ueda, K. Tsuboi, and T. Uyama Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways FEBS J. 280 2013 1874 1894
26. T. You, B.L. Disanzo, X. Wang, R. Yang, and D. Gong Adipose tissue endocannabinoid system gene expression: depot differences and effects of diet and exercise Lipids Health Dis. 10 2011 194
27. C. Silvestri, and V. Di Marzo The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders Cell Metab. 17 2013 475 490
28. L. Huang, M.A. Quinn, G.A. Frampton, L.E. Golden, and S. DeMorrow Recent advances in the understanding of the role of the endocannabinoid system in liver diseases Dig. Liver Dis. 43 2011 188 193
29. V. Chiurchiu, M. Lanuti, G. Catanzaro, F. Fezza, C. Rapino, and M. Maccarrone Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor Atherosclerosis 233 2014 55 63
30. Y. Okamoto, J. Morishita, K. Tsuboi, T. Tonai, and N. Ueda Molecular characterization of a phospholipase D generating anandamide and its congeners J. Biol. Chem. 279 2004 5298 5305
31. A. Chicca, J. Marazzi, S. Nicolussi, and J. Gertsch Evidence for bidirectional endocannabinoid transport across cell membranes J. Biol. Chem. 287 2012 34660 34682
32. F. Fezza, C. De Simone, D. Amadio, and M. Maccarrone Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system Subcell. Biochem. 49 2008 101 132
33. N. Ueda, K. Tsuboi, T. Uyama, and T. Ohnishi Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol Biofactors 37 2011 1 7
34. J.L. Blankman, G.M. Simon, and B.F. Cravatt A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol Chem. Biol. 14 2007 1347 1356
35. S. Valdeolivas, M.R. Pazos, T. Bisogno, F. Piscitelli, F.A. Iannotti, and M. Allara et al. The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG Cell Death Dis. 4 2013 e862
36. D.K. Nomura, B.E. Morrison, J.L. Blankman, J.Z. Long, S.G. Kinsey, and M.C. Marcondes et al. Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation Science 334 2011 809 813
37. S. Rossi, G. Bernardi, and D. Centonze The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis Exp. Neurol. 224 2010 92 102
38. S. Rossi, M. Bozzali, M. Bari, F. Mori, V. Studer, and C. Motta et al. Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis PLoS One 8 2013 e82848
39. S. Immenschuh Endocannabinoid signalling as an anti-inflammatory therapeutic target in atherosclerosis: does it work? Cardiovasc. Res. 84 2009 341 342
40. A.A. Izzo, F. Fezza, R. Capasso, T. Bisogno, L. Pinto, and T. Iuvone et al. Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation Br. J. Pharmacol. 134 2001 563 570
41. S. Fukuda, H. Kohsaka, A. Takayasu, W. Yokoyama, C. Miyabe, and Y. Miyabe et al. Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis BMC Musculoskelet. Disord. 15 2014 275
42. C. Lehmann, M. Kianian, J. Zhou, I. Kuster, R. Kuschnereit, and S. Whynot et al. Cannabinoid receptor 2 activation reduces intestinal leukocyte recruitment and systemic inflammatory mediator release in acute experimental sepsis Crit. Care 16 2012 R47
43. H. Gui, Y. Sun, Z.M. Luo, D.F. Su, S.M. Dai, and X. Liu Cannabinoid receptor 2 protects against acute experimental sepsis in mice Mediat. Inflamm. 2013 2013 741303
44. T. Mimura, S. Oka, H. Koshimoto, Y. Ueda, Y. Watanabe, and T. Sugiura Involvement of the endogenous cannabinoid 2 ligand 2-arachidonyl glycerol in allergic inflammation Int. Arch. Allergy Immunol. 159 2012 149 156
45. D.L. Scott, F. Wolfe, and T.W. Huizinga Rheumatoid arthritis Lancet 376 2010 1094 1108
46. D. Richardson, R.G. Pearson, N. Kurian, M.L. Latif, M.J. Garle, and D.A. Barrett et al. Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis Arthritis Res. Ther. 10 2 2008 R43
47. B. Bartok, and G.S. Firestein Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis Immunol. Rev. 233 2010 233 255
48. E. Neumann, S. Lefevre, B. Zimmermann, S. Gay, and U. Muller-Ladner Rheumatoid arthritis progression mediated by activated synovial fibroblasts Trends Mol. Med. 16 2010 458 468
49. H. Baumann, and I. Kushner Production of interleukin-6 by synovial fibroblasts in rheumatoid arthritis Am. J. Pathol. 152 1998 641 644
50. A. Mora, S.B. Abramsona, and M.H. Pillingera The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction Clin. Immunol. 115 2005 118 128
51. U. Muller-Ladner, and S. Gay MMPs and rheumatoid synovial fibroblasts: Siamese twins in joint destruction? Ann. Rheum. Dis. 61 2002 957 959
52. T.C.A. Tolboom, E. Pieterman, Laan WHvd, R.E.M. Toes, A.L. Huidekoper, and R.G.H.H. Nelissen et al. Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10 Ann. Rheum. Dis. 61 2002 975 980
53. J.K. Ahn, H. Kim, J. Lee, E.K. Bae, H.S. Cha, and E.M. Koh Phenotypic characterization and invasive properties of synovial fluid-derived adherent cells in rheumatoid arthritis Inflammation 31 2008 365 371
54. L. Hanus, A. Breuer, S. Tchilibon, S. Shiloah, D. Goldenberg, and M. Horowitz et al. HU-308: a specific agonist for CB2, a peripheral cannabinoid receptor Proc. Natl. Acad. Sci. U. S. A. 96 1999 14228 14233
55. F. Rossi, D. Siniscalco, L. Luongo, L. De Petrocellis, G. Bellini, and S. Petrosino et al. The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption Bone 44 2009 476 484
56. A.I. Idris, R.J. van't Hof, I.R. Greig, S.A. Ridge, D. Baker, and R.A. Ross et al. Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors Nat. Med. 11 2005 774 779
57. A. Sophocleous, E. Landao-Bassonga, R.J. van't Hof, A.I. Idris, and S.H. Ralston The type 2 cannabinoid receptor regulates bone mass and ovariectomy-induced bone loss by affecting osteoblast differentiation and bone formation Endocrinology 152 2011 2141 2149
58. A.I. Idris, A. Sophocleous, E. Landao-Bassonga, RJvt Hof, and S.H. Ralston Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor Endocrinology 149 2008 5619 5626
59. H. Gui, X. Liu, L.R. Liu, D.F. Su, and S.M. Dai Activation of cannabinoid receptor 2 attenuates synovitis and joint destruction in collagen-induced arthritis Immunobiology 2014 http://dx.doi.org/10.1016/j.imbio.2014.12.012, [Epub ahead of print]
60. S. Shiozawa, K. Shiozawa, and T. Fujita Morphologic observations in the early phase of the cartilage-pannus junction. Light and electron microscopic studies of active cellular pannus Arthritis Rheum. 26 1983 472 478
61. J. Mollenhauer, K. von der Mark, G. Burmester, K. Gluckert, E. Lutjen-Drecoll, and K. Brune Serum antibodies against chondrocyte cell surface proteins in osteoarthritis and rheumatoid arthritis J. Rheumatol. 15 1988 1811 1817
62. F. Hua, H. Sustackova, E. Keystone, R. Kandel, and T. Cruz Are antibodies reactive with chondrocyte proteins enriched in synovial fluids of patients with rheumatoid arthritis? Agents Actions Suppl. 39 1993 81 86
63. H.A. Kim, and Y.W. Song Apoptotic chondrocyte death in rheumatoid arthritis Arthritis Rheum. 42 1999 1528 1537
64. E.C. Mbvundula, R.A.D. Bunning, and K.D. Rainsford Arthritis and cannabinoids: HU-210 and Win-55,212-2 prevent IL-1alpha-induced matrix degradation in bovine articular chondrocytes in-vitro J. Pharm. Pharmacol. 58 2006 351 358
65. S.L. Dunn, J.M. Wilkinson, A. Crawford, C.L. Le Maitre, and R.A. Bunning Cannabinoid WIN-55,212-2 mesylate inhibits interleukin-1beta induced matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human chondrocytes Osteoarthr. Cartil. 22 2014 133 144
66. M.T. Cencioni, V. Chiurchiu, G. Catanzaro, G. Borsellino, G. Bernardi, and L. Battistini et al. Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors PLoS One 5 2010 e8688
67. K. Coopman, L.D. Smith, K.L. Wright, and S.G. Ward Temporal variation in CB2R levels following T lymphocyte activation: evidence that cannabinoids modulate CXCL12-induced chemotaxis Int. Immunopharmacol. 7 2007 360 371
68. A. Guillot, N. Hamdaoui, A. Bizy, K. Zoltani, R. Souktani, and E.S. Zafrani et al. Cannabinoid receptor 2 counteracts interleukin-17-induced immune and fibrogenic responses in mouse liver Hepatology 59 2014 296 306
69. M.M. Fung, Y.L. Chu, J.L. Fink, A. Wallace, and K.L. McGuire IL-2- and STAT5-regulated cytokine gene expression in cells expressing the Tax protein of HTLV-1 Oncogene 24 2005 4624 4633
70. Y. Daaka, H. Friedman, and T.W. Klein Cannabinoid receptor proteins are increased in Jurkat, human T-cell line after mitogen activation J. Pharmacol. Exp. Ther. 276 1996 776 783
71. C. Borner, V. Hollt, and J. Kraus Activation of human T cells induces upregulation of cannabinoid receptor type 1 transcription Neuroimmunomodulation 14 2007 281 286
72. M.E. Doorenspleet, P.L. Klarenbeek, M.J. de Hair, B.D. van Schaik, R.E. Esveldt, and A.H. van Kampen et al. Rheumatoid arthritis synovial tissue harbours dominant B-cell and plasma-cell clones associated with autoreactivity Ann. Rheum. Dis. 73 2014 756 762
73. A.L. Fedele, B. Tolusso, E. Gremese, S.L. Bosello, A. Carbonella, and S. Canestri et al. Memory B cell subsets and plasmablasts are lower in early than in long-standing. Rheumatoid arthritis. BMC Immunol. 15 2014 28
74. P. Carayon, J. Marchand, D. Dussossoy, J.M. Derocq, O. Jbilo, and A. Bord et al. Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation Blood 92 1998 3605 3615
75. M. Agudelo, C. Newton, R. Widen, T. Sherwood, L. Nong, and H. Friedman et al. Cannabinoid receptor 2 (CB2) mediates immunoglobulin class switching from IgM to IgE in cultures of murine-purified B lymphocytes J. Neuroimmune Pharmacol. 3 2008 35 42
76. S.F. Lee, C. Newton, R. Widen, H. Friedman, and T.W. Klein Differential expression of cannabinoid CB(2) receptor mRNA in mouse immune cell subpopulations and following B cell stimulation Eur. J. Pharmacol. 423 2001 235 241
77. S.F. Lee, C. Newton, R. Widen, H. Friedman, and T.W. Klein Downregulation of cannabinoid receptor 2 (CB2) messenger RNA expression during in vitro stimulation of murine splenocytes with lipopolysaccharide Adv. Exp. Med. Biol. 493 2001 223 228
78. J.P. Pereira, J. An, Y. Xu, Y. Huang, and J.G. Cyster Cannabinoid receptor 2 mediates the retention of immature B cells in bone marrow sinusoids Nat. Immunol. 10 2009 403 411
79. S. Basu, A. Ray, and B.N. Dittel Cannabinoid receptor 2 is critical for the homing and retention of marginal zone B lineage cells and for efficient T-independent immune responses J. Immunol. 187 2011 5720 5732
80. J.R. Muppidi, T.I. Arnon, Y. Bronevetsky, N. Veerapen, M. Tanaka, and G.S. Besra et al. Cannabinoid receptor 2 positions and retains marginal zone B cells within the splenic marginal zone J. Exp. Med. 208 2011 1941 1948
81. S. Basu, A. Ray, and B.N. Dittel Cannabinoid receptor 2 (CB2) plays a role in the generation of germinal center and memory b cells, but not in the production of antigen-specific IgG and IgM, in response to T-dependent antigens PLoS One 8 2013 e67587
82. G. Yanni, A. Whelan, C. Feighery, and B. Bresnihan Synovial tissue macrophages and joint erosion in rheumatoid arthritis Ann. Rheum. Dis. 53 1994 39 44
83. J.J. Haringman, D.M. Gerlag, A.H. Zwinderman, T.J. Smeets, M.C. Kraan, and D. Baeten et al. Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis Ann. Rheum. Dis. 64 2005 834 838
84. P. Massi, M. Valenti, D. Bolognini, and D. Parolaro Expression and function of the endocannabinoid system in glial cells Curr. Pharm. Des. 14 2008 2289 2298
85. P.F. Sumariwalla, R. Gallily, S. Tchilibon, E. Fride, R. Mechoulam, and M. Feldmann A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritis Arthritis Rheum. 50 2004 985 998
86. F.L. Smith, K. Fujimori, J. Lowe, and S.P. Welch Characterization of d9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats Pharmacol. Biochem. Behav. 60 1998 183 191
87. A.M. Malfait, R. Gallily, P.F. Sumariwalla, A.S. Malik, E. Andreakos, and R. Mechoulam et al. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis Proc. Natl. Acad. Sci. U. S. A. 97 2000 9561 9566